A detailed history of Sawtooth Solutions, LLC transactions in Dexcom Inc stock. As of the latest transaction made, Sawtooth Solutions, LLC holds 6,758 shares of DXCM stock, worth $542,261. This represents 0.02% of its overall portfolio holdings.

Number of Shares
6,758
Previous 15,265 55.73%
Holding current value
$542,261
Previous $1.42 Million 41.15%
% of portfolio
0.02%
Previous 0.05%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Jan 29, 2024

SELL
$75.49 - $124.16 $642,193 - $1.06 Million
-8,507 Reduced 55.73%
6,758 $838,000
Q3 2023

Oct 19, 2023

SELL
$86.06 - $137.93 $137,782 - $220,825
-1,601 Reduced 9.49%
15,265 $1.42 Million
Q2 2023

Jul 26, 2023

SELL
$112.47 - $130.98 $117,531 - $136,874
-1,045 Reduced 5.83%
16,866 $2.17 Million
Q1 2023

Apr 27, 2023

BUY
$104.0 - $122.92 $1.34 Million - $1.58 Million
12,878 Added 255.87%
17,911 $2.08 Million
Q4 2022

Feb 02, 2023

BUY
$84.98 - $122.67 $87,444 - $126,227
1,029 Added 25.7%
5,033 $569,000
Q3 2022

Oct 12, 2022

SELL
$76.35 - $94.18 $916 - $1,130
-12 Reduced 0.3%
4,004 $322,000
Q2 2022

Jul 19, 2022

BUY
$67.99 - $132.89 $212,536 - $415,414
3,126 Added 351.24%
4,016 $299,000
Q1 2022

May 20, 2022

SELL
$94.08 - $130.2 $71,688 - $99,212
-762 Reduced 46.13%
890 $455,000
Q4 2021

Feb 11, 2022

BUY
$129.87 - $162.82 $126,753 - $158,912
976 Added 144.38%
1,652 $888,000
Q3 2021

Nov 09, 2021

BUY
$106.71 - $143.18 $13,979 - $18,756
131 Added 24.04%
676 $370,000
Q2 2021

Sep 01, 2021

BUY
$80.99 - $107.93 $44,139 - $58,821
545 New
545 $233,000
Q3 2020

Nov 04, 2020

SELL
$95.51 - $112.95 $321,773 - $380,528
-3,369 Closed
0 $0
Q2 2020

Aug 06, 2020

BUY
$62.68 - $105.34 $211,168 - $354,890
3,369 New
3,369 $1.37 Million

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $31B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Sawtooth Solutions, LLC Portfolio

Follow Sawtooth Solutions, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sawtooth Solutions, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sawtooth Solutions, LLC with notifications on news.